Our model's win probability vs. the market's implied probability. The gap is the edge.
Every factor that moved the model. Every number sourced — no hallucinations.
The Dodgers' runline sits at +140 despite Supreme Brain assigning it a 50.0% win probability—identical to the market-implied probability at current odds. That mispricing creates a +5.0% expected-value edge on a road favorite getting plus money on the runline, a rare pricing inefficiency. The model sizes this to 0.14 units via quarter-Kelly staking. The thesis is simple: when the chalk team offers plus money on a two-run spread, you're being paid to fade single-run variance. Los Angeles carries fifteen players on the injury report compared to Minnesota's eight, but the line hasn't adjusted enough to reflect the Dodgers' ability to win decisively. The edge is narrow—just 1.8% after vig—but the price is right for a measured play on a team that shouldn't be offering this return on a runline.
Supreme Brain assigns the Dodgers' runline a 50.0% win probability at +140 odds—exactly matching the market-implied probability at that price. That equilibrium shouldn't exist when you're getting plus money on a road favorite's two-run spread.
The model identifies a +5.0% expected-value edge (+1.8% after vig) on LAD -1.5, sized to 0.14 units via quarter-Kelly, because plus-money runline pricing on the chalk team misprices the Dodgers' ability to win decisively on the road.
Single-run wins kill the runline, and that's the most likely failure mode here. If the Dodgers win 3-2 or 4-3—entirely plausible given their injury list and the road environment—you lose despite backing the correct side. The other risk is that the market knows something the model doesn't about Los Angeles' ability to score in bunches with fifteen players sidelined. If the offense is more compromised than the line suggests, even a win becomes a sweat.
You're being paid +140 to fade the one-run game, and the model says that's worth 0.14 units. When the chalk offers plus money on a runline, the edge is in taking it.